BOSTON–(BUSINESS WIRE)–Ora, Inc., leading ophthalmology CRO, announcing inclusion in the NHS 75: Celebrating 75 Years of the National Health Service book launching today.
Author: Business Wire
National Vision Holdings, Inc. Announces Participation in the Goldman Sachs 30th Annual Global Retailing Conference
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) today announced that members of its management team are scheduled to participate in a fireside chat session at the Goldman Sachs 30th Annual Global Retailing Conference on Tuesd…
DigitalOptometrics to Demonstrate Its Remote Comprehensive Exam Services With Instant Language Translation Capabilities at Vision Expo West
LAKE SUCCESS, N.Y.–(BUSINESS WIRE)– #digitaloptometrics–D.O., the remote eye exam service, will demo at Vision Expo West. Interact with remote optometrists and experience patient-centric comprehensive exams
Revolutionizing Glaucoma Management: Emerging Therapies Projected to Drive Global Market to 2032 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Glaucoma Market Insight, Epidemiology and Market Forecast – 2032” report has been added to ResearchAndMarkets.com’s offering. The global glaucoma market is set for substantial growth. The market’s Compound Annual Growth Ra…
EyeSouth Partners Affiliates with Retina and Vitreous of Texas, Representing Its 38th Affiliation and First Retina Practice in Texas
ATLANTA–(BUSINESS WIRE)–EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has partnered with Retina and Vitreous of Texas (“RVT”), one of Houston’s leading retina-only practices. The affiliation represents EyeSouth’s thir…
Vivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10
EMERYVILLE, Calif.–(BUSINESS WIRE)–Vivani Medical, Inc. (NASDAQ: VANI), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, announced today that its wholly-owned subsidiary Cortigent, Inc., a company …
Global Eye Care Market Analysis Report 2023: A $173.9 Billion Market by 2031 – Rising Prevalence of Vision Problems Drives Demand for Corrective Eyewear and Advanced Contact Lenses – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Eye Care Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global eye care market size was valued at USD 112.5 billion in 2022, driven by the increasing prevalence…
New York Structural Biology Center and Syncell Announce Partnership for Microscopy-Guided Proteomics
NEW YORK & TAIPEI, Taiwan–(BUSINESS WIRE)–The New York Structural Biology Center (NYSBC), a global leading institute in structural biology, and Syncell, a life science tools company pioneering the technology of microscopy-guided proteomics discovery,…
VTI Appoints Dr. Juan Carlos Aragón as CEO and Executive Director
ATLANTA–(BUSINESS WIRE)–US-based medical device firm, Visioneering Technologies, Inc (ASX:VTI), announced the hiring of Dr. Juan Carlos Aragón as Chief Executive Officer and Executive Director, starting October 1, 2023. Bringing over 30 years of expe…
The Hartford Enhances Employee Benefits For Small Businesses Through New Relationship With Beam Benefits
HARTFORD, Conn.–(BUSINESS WIRE)–The Hartford, a leading provider of employee benefits and small business insurance, is enhancing its benefit options for small businesses with dental and vision plans through a new relationship with Beam Benefits. Brok…
International Color Blindness Awareness Month Nets Huge Turnout
BERKELEY, Calif.–(BUSINESS WIRE)– #enchroma–Over 160 Organizations Team with EnChroma to Support International Color Blindness Awareness Month Including Major Companies, Museums & Universities
Bausch + Lomb Will Participate at the 2023 Wells Fargo Healthcare Conference
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders is scheduled to participate a…
Dr. Parul Khator Becomes First Doctor In Georgia to Use the iTrack Advance Canaloplasty Device for Glaucoma
ATLANTA–(BUSINESS WIRE)–Georgia Eye Partners is proud to share that Dr. Parul Khator has become the first eye surgeon in Georgia to utilize the iTrack Advance Canaloplasty Device, a minimally invasive glaucoma surgical device (MIGS) used to reduce in…
KeraLink International Unveils Groundbreaking Strategy to Eradicate Corneal Blindness
BALTIMORE–(BUSINESS WIRE)–KeraLink International, a charitable organization and leader in corneal health innovation, unveils major initiatives to eradicate corneal blindness.
欧洲药品管理局接受Novaliq的0.1% CyclASol®（环孢霉素眼用溶液）治疗干眼病的上市许可申请
德国海德堡和美国马萨诸塞州剑桥–(BUSINESS WIRE)–(美国商业资讯)– 专注于一流眼部治疗方案的生物制药公司Novaliq GmbH今天宣布，欧洲药品管理局（European Medicines Agency，EMA）已接受CyclASol（环孢素眼用溶液）的上市授权申请（marketing authorization application，以下简称“MAA”），并会进行监管审查。CyclASol是一种正在研发的新药，用于治疗泪液替代物无效的干眼症患者。欧洲药品管理局的人用药品委…
L'Agence européenne des médicaments accepte la demande d'autorisation de commercialisation de Novaliq pour CyclASol® (collyre à base de ciclosporine) 0,1 % pour le traitement de la sécheresse oculaire
HEIDELBERG, Allemagne & CAMBRIDGE, Massachusetts–(BUSINESS WIRE)–Novaliq GmbH, une société biopharmaceutique axée sur les thérapies oculaires de pointe, a annoncé aujourd’hui que l’Agence européenne des médicaments (EMA) a accepté sa demande d’autori…
La Agencia Europea del Medicamento acepta la solicitud de autorización de comercialización de Novaliq para CyclASol® (solución oftálmica de ciclosporina) al 0,1 % para el tratamiento del ojo seco
HEIDELBERG, Alemania y CAMBRIDGE, Massachusetts–(BUSINESS WIRE)–Novaliq GmbH, empresa biofarmacéutica especializada en terapias oculares innovadoras, ha anunciado hoy que la Agencia Europea del Medicamento (EMA) ha aceptado la solicitud de autorizaci…
Europees geneesmiddelenbureau aanvaardt de aanvraag van Novaliq voor een vergunning voor het op de markt brengen van CyclASol® (ciclosporine oogheelkundige oplossing) 0,1% voor de behandeling van droge-ogenziekte
HEIDELBERG, Duitsland & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Novaliq GmbH, een biofarmaceutisch bedrijf dat zich richt op eerste- en topklasse oogheelkundige geneesmiddelen, heeft vandaag aangekondigd dat het Europees Geneesmiddelenbureau (EMA) de aanvra…
L'Agenzia Europea dei Medicinali accetta la richiesta di autorizzazione all'immissione in commercio di Novaliq per CyclASol ® (ciclosporina soluzione oftalmica) 0,1% per il trattamento della malattia dell'occhio secco
HEIDELBERG, Germania e CAMBRIDGE, Massachusetts.–(BUSINESS WIRE)–Novaliq GmbH, un’azienda biofarmaceutica che si occupa di terapie oculari best in class, ha annunciato oggi che l’Agenzia Europea dei Medicinali (EMA) ha accettato la domanda di autoriz…
Die Europäische Arzneimittelagentur genehmigt den Zulassungsantrag von Novaliq für CyclASol® Ciclosporin-Augenlösung) 0,1 % zur Behandlung von trockenen Augen
HEIDELBERG, Deutschland & CAMBRIDGE, Massachusetts.–(BUSINESS WIRE)–Die Novaliq GmbH, ein Biopharma-Unternehmen, das sich auf innovative und erstklassige Augentherapeutika konzentriert, gab heute die Genehmigung des Antrags auf Marktzulassung (Market…